Open surgical release of a contracted shoulder joint capsule to restore glenohumeral range of motion, typically performed for adhesive capsulitis or post-traumatic stiffness.
Verified May 8, 2026 · 7 sources ↓
- Medicare
- $650.65
- Total RVUs
- 19.48
- Global, days
- 90
- Region
- Shoulder
Documentation requirements
What must appear in the operative or office note to support the claim.
Source · Editorial brief grounded in 7 cited references ↓
- Named surgical approach (e.g., deltopectoral) documented in operative note — 'standard approach' flags audits
- Specific description of capsular pathology found intraoperatively, including location and extent of contracture
- Documented failure of conservative treatment (e.g., physical therapy, injections) supporting medical necessity
- If billed with arthroplasty or other shoulder procedures, separate documentation of distinct surgical steps and pathology justifying each additional code
- Pre-operative diagnosis referencing the condition causing the contracture (e.g., adhesive capsulitis, post-traumatic stiffness)
- Range-of-motion measurements pre-operatively to establish functional limitation baseline
Applicable modifiers
Modifiers commonly billed with this code.
Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual
What this code covers
Source · Editorial summary grounded in 7 cited references ↓
CPT 23020 describes an open capsular release of the shoulder — the Sever type procedure — where the surgeon incises or releases a thickened, contracted joint capsule to restore glenohumeral mobility. The procedure is indicated when conservative measures have failed to resolve a stiff or frozen shoulder, including cases of adhesive capsulitis, post-operative capsular fibrosis, or contracture following fracture or arthroplasty. The deltopectoral or alternative approach is used to access and release the offending capsular tissue.
Bundling is a significant billing concern with 23020. When performed alongside total shoulder arthroplasty (23472), payers — including Medicare — frequently consider the capsular release integral to the arthroplasty and will deny 23020 as a separately reported code. The AAPC forum documentation and peer coding review confirm this bundling risk. If the release is genuinely a distinct, additional component beyond the routine exposure, that distinction must be explicit in the operative note with separate documentation of pathology and surgical steps.
The code carries a 90-day global period under CMS PFS 2026. Any E/M visit related to the shoulder in that window requires modifier 24. If a same-day E/M preceded the decision for surgery, modifier 57 applies. Bilateral performance is rare but billable with modifier 50.
RVU & reimbursement
Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.
Source · CMS Physician Fee Schedule, RVU26A · January 2026
| Work RVU | 9.13 |
| Practice expense RVU | 8.44 |
| Malpractice RVU | 1.91 |
| Total RVU | 19.48 |
| Medicare national rate | $650.65 |
| Global period | 90 days |
Payment by site of service
Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.
Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026
| Setting | Medicare rate (national) |
|---|---|
Office (PFS non-facility) Procedure performed in physician's office | $650.65 |
HOPD (APC 5113) Hospital outpatient department | $3,342.87 |
ASC (PI A2) Ambulatory surgical center (freestanding) | $1,644.87 |
Common denial reasons
The recurring reasons claims for CPT 23020 get rejected.
Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓
- Bundled into 23472 (total shoulder arthroplasty) when capsular release is considered integral to the arthroplasty approach — no separate payment without distinct documentation
- Medical necessity denied when pre-operative documentation lacks evidence of failed conservative treatment or functional limitation
- Laterality modifier missing (LT or RT), triggering claim suspension or denial for unspecified side
- Global period conflict — E/M billed post-operatively for a related shoulder complaint without modifier 24
- Operative note describes only a generic capsular release without naming the procedure, approach, or capsular pathology, failing to support the code
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 7 cited references ↓
01Can 23020 be billed alongside 23472 (total shoulder arthroplasty)?
02Is 23020 an open procedure only, or can it be reported for arthroscopic release?
03What modifiers are required when billing 23020 for Medicare?
04What is the global period for 23020, and what does that cover?
05How does site of service affect reimbursement for 23020?
06When is modifier 22 justified for 23020?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CMS Physician Fee Schedule 2026
- 02cms.govhttps://www.cms.gov/files/document/04-chapter4-ncci-medicare-policy-manual-2026-final.pdf
- 03aapc.comhttps://www.aapc.com/discuss/threads/shoulder-coding-looking-for-reassurance.97989/
- 04mdclarity.comhttps://www.mdclarity.com/cpt-code/23020
- 05emedny.orghttps://www.emedny.org/providermanuals/physician/pdfs/physician%20procedure%20codes%20sect5.pdf
- 06faculty.washington.eduhttps://faculty.washington.edu/alexbert/Shoulder/Codes.htm
- 07cgsmedicare.comhttps://www.cgsmedicare.com/medicare_dynamic/j15/partb/ptpb/ptp.aspx
Mira AI Scribe
Mira's AI scribe captures the surgical approach by name, the specific capsular structures released, intraoperative findings describing the degree and location of contracture, and any concurrent procedures with their independent pathology. This prevents the most common denial scenario: an operative note that reads as if the capsular release was just part of the exposure for another procedure, rather than a separately documented and medically necessary surgical step.
See how Mira captures CPT 23020 documentation